Hydrofarm Holdings Group's biggest risks in the FY2024 10-K
- Hydrofarm faces significant exposure to federal cannabis illegality, supply chain disruptions, international tariffs, and restructuring execution risks.
The risks most specific to Hydrofarm Holdings Group
- Risks Relating to Our Business
Our restructuring activities may increase our expenses and cash expenditures, and may not have the intended effects
Restructuring initiatives designed to streamline operations during the industry recession may increase expenses and cash expenditures without achieving intended effects.
- Risks Relating to Our Business
Long-lived assets and inventories represent a significant portion of our total assets and we may be required to record impairments or write-downs in future periods
The consolidated balance sheet includes $249.0 million of intangible assets, $50.6 million of inventories, and $37.5 million of property, plant, and equipment subject to future write-downs.
- Risks Relating to Our Business
Our peat bogs are susceptible to sudden changes in weather and the impacts of climate change
The peat moss harvesting operation in Alberta, Canada relies on predictable weather, and excess rain impedes vacuum harvesters.
- Risks Relating to Our Business
Potential tariffs or a global trade war could increase the cost of our products, which could adversely impact the competitiveness of our products and our financial results
U.S. tariffs on lighting and environmental control equipment manufactured in China can increase product costs and reduce competitiveness.
- Risks Relating to Our Business
We may be limited in our ability to utilize, or may not be able to utilize, net operating loss carryforwards to reduce our future tax liability
U.S. federal net operating loss carryforwards of approximately $183.8 million may be limited annually due to Section 382 change in ownership provisions.
- Risks Relating to Our Indebtedness
The Credit Facilities have restrictions on our ability to sell our products directly to the cannabis industry
Credit Facilities prohibit selling products directly to cannabis growers operating in countries where cannabis sales are illegal.
- Risks Relating to Our Indebtedness
Substantially all of our and our Subsidiary Obligors’ assets are pledged to secure obligations under the Credit Facilities
Substantially all assets of Hydrofarm and Subsidiary Obligors are pledged to secure obligations under the JPMorgan Credit Facilities.
- Risks Relating to the Cannabis Industry
We are subject to a number of risks, directly and indirectly through Cannabis Industry Participants, because cannabis is illegal under federal law
Cannabis remains illegal under U.S. federal law, and federal enforcement actions may negatively impact revenues and profits.
- Risks Relating to the Cannabis Industry
Cannabis Industry Participants are subject to federal and state controlled substance laws and regulations. As a result, we are indirectly subject to a number of risks related to controlled substances
Products sold to Cannabis Industry Participants expose the company to risks related to federal and state controlled substance laws.
All 68 risk factors
Headings as the filing states them, in filing order.
Risks Relating to Our Business
- 01Our competitors and potential competitors may develop products and technologies that are more effective or commercially attractive than our products
- 02Our restructuring activities may increase our expenses and cash expenditures, and may not have the intended effects
- 03We may not successfully develop new products or improve existing products or maintain our effectiveness in reaching consumers through rapidly evolving communication vehicles
- 04Long-lived assets and inventories represent a significant portion of our total assets and we may be required to record impairments or write-downs in future periods
- 05If we fail to manage our inventory effectively, our results of operations, financial condition and liquidity may be materially and adversely affected
- 06Our inventory is vulnerable to damage or loss caused by accidents or natural disasters, and we face the risk of theft of our products from inventory or during shipment
- 07We are exposed to manufacturing risks that could adversely affect our business and results of operations
- 08Our peat bogs are susceptible to sudden changes in weather and the impacts of climate change
- 09A significant product defect or product recall could materially and adversely affect our brand image, causing a decline in our sales and profitability, and could reduce or deplete our financial resources
- 10Our proprietary brand offerings expose us to various risks
- 11Potential tariffs or a global trade war could increase the cost of our products, which could adversely impact the competitiveness of our products and our financial results
- 12Increased prices and inflation could negatively impact our margin performance and our financial results
- 13We occupy many of our facilities under long-term non-cancellable leases, and we may be unable to renew, sublease or terminate and exit our leases
- 14A disruption in the operations of our freight carriers, higher shipping costs or shipping delays could disrupt our supply chain and could negatively impact our margin performance and our financial results
- 15Our international operations make us susceptible to the costs and risks associated with operating internationally
- 16Government laws and regulations, including environmental laws and regulations, could result in material costs or otherwise adversely affect our financial condition and results of operations
- 17regulations result in increased product or administrative costs, we may not be in a position to increase selling prices, and therefore an increase in costs could have a material adverse effect on our business, financial condition and results of operations
- 18Failure to optimize our supply chain or disruption of our supply chain could have an adverse effect on our business, financial condition and results of operations
- 19Increasing scrutiny and evolving expectations from customers, regulators, investors, and other stakeholders with respect to our environmental, social and governance practices may impose additional costs on us or expose us to new or additional risks
- 20Climate change may impact the availability of our facilities, we may incur substantial costs to comply with climate change legislation and related regulatory initiatives, and weather conditions could adversely impact financial results
- 21If we fail to maintain effective internal controls over financial reporting or fail to comply with other regulations, investors may lose confidence in the accuracy and completeness of our financial reporting, and the price of our common stock may be adversely affected
- 22We are a "smaller reporting company" and, because we have opted to use the reduced reporting requirements available to us, certain investors may find investing in our securities less attractive
- 23Damage to our reputation could have an adverse effect on our business
- 24Our marketing activities may not be successful
- 25Our operations may be impaired if our information technology systems, or those of our third-party vendors, fail to perform adequately or if we or our third-party vendors are the subject of a data breach or cyber-attack
- 26The estimates and judgments we make, or the assumptions on which we rely, in preparing our consolidated financial statements could prove inaccurate
- 27Unanticipated changes in our tax provisions, the adoption of new tax legislation or exposure to additional tax liabilities could affect our profitability and cash flows
- 28We may be limited in our ability to utilize, or may not be able to utilize, net operating loss carryforwards to reduce our future tax liability
- 29Acquisitions, other strategic alliances and investments could result in operating difficulties, dilution, and other harmful consequences that may adversely impact our business and results of operations
- 30If we need additional capital to fund our operations, we may not be able to obtain sufficient capital and may be forced to limit the scope of our operations
- 31If product liability lawsuits are brought against us, we may incur substantial liabilities
Risks Relating to Our Indebtedness
- 32The Credit Facilities have restrictions on our ability to sell our products directly to the cannabis industry
- 33Substantially all of our and our Subsidiary Obligors’ assets are pledged to secure obligations under the Credit Facilities
Risks Relating to Third Parties
- 34Disruptions in the availability or increases in the prices of raw materials sourced by suppliers could adversely affect our results of operations
- 35If our suppliers that currently, or will in the future, sell directly to the retail market in which we conduct our current or future business, or if our customers that currently, or will in the future, manufacture and sell competitive products, our ability to sell certain products could be harmed
- 36Disruption in our global supply chain or vendor relationships may negatively impact our businesses
- 37A significant interruption in the operation of our or our suppliers’ facilities could impact our capacity to produce products and service our customers, which could adversely affect revenues and earnings
- 38If our suppliers are unable to source raw materials in sufficient quantities, on a timely basis, and at acceptable costs, our ability to sell our products may be harmed
Risks Relating to the Cannabis Industry
- 39We are subject to a number of risks, directly and indirectly through Cannabis Industry Participants, because cannabis is illegal under federal law
- 40Cannabis Industry Participants are subject to federal and state controlled substance laws and regulations. As a result, we are indirectly subject to a number of risks related to controlled substances
- 41any from the DEA or otherwise arising under federal law. We could be implicated in such enforcement or sanctions because of the purchase of our products by such Cannabis Industry Participants
- 42Furthermore, the Credit Facilities restrict our ability and the ability of the Subsidiary Obligors to sell our products directly to U.S. cannabis growers
- 43Certain of our products may be purchased for use in new and emerging industries and/or be subject to varying, inconsistent, and rapidly changing laws, regulations, administrative practices, enforcement approaches, judicial interpretations, future scientific research and public perception
- 44acceptance in a manner that we can predict. The demand for these products is dependent on the growth of these industries, which is uncertain, as well as the laws governing the growth, possession, and use of cannabis by adults for both adult and medical use
- 45Our indirect involvement in the cannabis industry could affect the public’s perception of us and be detrimental to our reputation
- 46Businesses involved in the cannabis industry, and investments in such businesses, are subject to a variety of laws and regulations related to money laundering, financial recordkeeping and proceeds of crimes
Risks Relating to Other Regulations
- 47Certain state and other regulations pertaining to the use of certain ingredients in grow media and plant nutrients could adversely impact us by restricting our ability to sell such products
- 48We are currently subject to, and may in the future become subject to additional, U.S., state and foreign laws and regulations imposing obligations on how we collect, store and process personal information. Our actual or perceived failure to comply with such obligations could harm our business
- 49Compliance with, or violation of, environmental, health and safety laws and regulations, including laws pertaining to the use of pesticides, could result in significant costs that adversely impact our reputation, businesses, financial position, results of operations and cash flows
Risks Relating to Our Intellectual Property
- 50We may not be able to adequately obtain, maintain, protect or enforce our intellectual property and other proprietary rights that are material to our business
- 51Obtaining and maintaining our patent protection depends on compliance with various procedural, document submissions, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for noncompliance with these requirements
- 52From time to time, we may need to rely on licenses to proprietary technologies, which may be difficult or expensive to obtain or we may lose certain licenses which may be difficult to replace, harming our competitive position
- 53Third parties may initiate legal proceedings alleging that we are infringing their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of our business
- 54Intellectual property disputes could cause us to spend substantial resources and distract our personnel from their normal responsibilities
- 55If our owned or in-licensed trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected
Risks Relating to Our Capital Stock
- 56We may incur indebtedness or issue capital stock that ranks senior or equally to our common stock as to liquidation preference and other rights and which may dilute our stockholders’ ownership interest
- 57Provisions in our corporate charter documents and under Delaware law could make an acquisition of our company, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management
- 58Various provisions of our lending agreements with JPMorgan, in addition to our Certificate of Incorporation, Bylaws and other corporate documents, could delay or prevent a change of control
- 59We may not meet continued listing requirements, our common stock may be delisted from the Nasdaq Capital Market, which could affect the market price and liquidity for our common stock and reduce our ability to raise additional capital
- 60The market price of our common stock could be negatively affected by future sales of our common stock
- 61The price of our common stock has been, and may continue to be, volatile and may fluctuate substantially, which could result in substantial losses for purchasers of our common stock
- 62Our Certificate of Incorporation provides that the doctrine of "corporate opportunity" will not apply with respect to any director or stockholder who is not employed by us or our affiliates
- 63If we are unable to retain key personnel, we may not be able to implement our business plan and our business may fail; our headcount reductions may cause undesirable consequences
- 64Litigation may adversely affect our business, financial condition and results of operations
- 65Our equity incentive plans may have a dilutive effect on your percentage ownership and may result in a dilution of your voting power and an increase in the number of shares of common stock eligible for future resale in the public market, which may negatively impact the trading price of our shares of common stock
- 66Our security holders may be diluted by future issuances of securities by us
- 67Failure to comply with the U.S. Foreign Corrupt Practices Act could subject us to penalties and other adverse consequences
- 68Delaware law contains anti-takeover provisions that could deter takeover attempts that could be beneficial to our stockholders
Other Hydrofarm Holdings Group 10-Ks
- FY2025 10-K risk factors70 risks5 new3 dropped10 reworded
Hydrofarm faces severe liquidity constraints, a going concern warning, and a $2.8 million deferred interest payment default on its Term Loan. The company breached Nasdaq minimum equity rules and recorded massive impairment charges of $232.2 million in 2025.
Filed Mar 27, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.